Immunic to present new vidofludimus calcium data at MSToronto2026

Immunic said four accepted abstracts on vidofludimus calcium will be presented at the October 21-23 MSToronto2026 meeting in Toronto. The company also highlighted new CALLIPER open-label extension data and preclinical and biomarker findings in multiple sclerosis.